Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
MediaAlpha | MAX | Nov 29, 2024 | 12.63 | -2.02 |
Mediaco A | MDIA | Nov 29, 2024 | 1.29 | -3.73 |
Medical Properties Trust | MPW | Nov 29, 2024 | 4.39 | +1.39 |
MediciNova | MNOV | Nov 29, 2024 | 2.07 | +2.99 |
Medicus Pharma | MDCX | Nov 29, 2024 | 2.70 | 0.00 |
Medifast | MED | Nov 29, 2024 | 19.67 | +1.18 |
MEDIROM Healthcare Technologies ADR | MRM | Nov 29, 2024 | 3.39 | +7.30 |
MediWound | MDWD | Nov 29, 2024 | 17.47 | +0.11 |
Mednax | MD | Nov 29, 2024 | 14.96 | +1.29 |
Medpace | MEDP | Nov 29, 2024 | 340.63 | +0.49 |
Medtronic | MDT | Nov 29, 2024 | 86.54 | +0.31 |
Mega Matrix | MPU | Nov 29, 2024 | 1.80 | -1.10 |
Megacap 300 Growth Index ETF Vanguard | MGK | Nov 29, 2024 | 340.02 | +0.90 |
Megacap 300 Index ETF Vanguard | MGC | Nov 29, 2024 | 216.46 | +0.67 |
Megacap 300 Value Index ETF Vanguard | MGV | Nov 29, 2024 | 133.48 | +0.32 |
MEI Pharma | MEIP | Nov 29, 2024 | 2.82 | +0.71 |
Meihua International Medical Technologies | MHUA | Nov 29, 2024 | 0.53 | -1.82 |
MeiraGTx Holdings | MGTX | Nov 29, 2024 | 6.77 | +3.36 |
Meiwu Technology | WNW | Nov 29, 2024 | 0.98 | -2.09 |
Melar Acquisition I | MACI | Nov 29, 2024 | 10.04 | -0.21 |
Melar Acquisition I | MACIU | Nov 29, 2024 | 10.14 | 0.00 |
Melco Resorts & Entertainment ADR | MLCO | Nov 29, 2024 | 6.42 | +3.55 |
MercadoLibre | MELI | Nov 29, 2024 | 1 985.17 | -2.91 |
Mercantile Bank | MBWM | Nov 29, 2024 | 50.05 | -0.95 |
Mercer International | MERC | Nov 29, 2024 | 6.17 | -0.64 |
Merchants Bancorp | MBIN | Nov 29, 2024 | 41.28 | -0.12 |
Merchants Bancorp B | MBINO | Nov 29, 2024 | 25.45 | +0.08 |
Merchants Bancorp C Pref | MBINN | Nov 29, 2024 | 22.99 | +0.72 |
Merchants Bancorp Pref D | MBINM | Nov 29, 2024 | 26.03 | -0.08 |
Merck & Co | MRK | Nov 29, 2024 | 101.64 | -1.44 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.